S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 HumanigenDyne TherapeuticsAnnexonCara TherapeuticsEnanta Pharmaceuticals
SymbolNASDAQ:HGENNASDAQ:DYNNASDAQ:ANNXNASDAQ:CARANASDAQ:ENTA
Price Information
Current Price$18.59$18.47$29.11$18.35$49.32
52 Week RangeBuyBuyBuyBuyHold
MarketRank™
Overall Score1.71.61.71.81.4
Analysis Score3.43.52.53.53.2
Community Score3.53.63.93.12.3
Dividend Score0.00.00.00.00.0
Ownership Score0.80.81.71.71.7
Earnings & Valuation Score0.60.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$27.83$34.25$34.33$34.50$64.63
% Upside from Price Target49.72% upside85.44% upside17.94% upside88.01% upside31.03% upside
Trade Information
Market Cap$959.56 million$839.41 million$1.11 billion$914.42 million$994.88 million
Beta-0.79N/AN/A1.70.54
Average Volume809,612531,755136,452548,814153,538
Sales & Book Value
Annual RevenueN/AN/AN/A$19.89 million$122.47 million
Price / SalesN/AN/AN/A45.978.12
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.63) per shareN/AN/A$4.66 per share$22.70 per share
Price / BookN/AN/AN/A3.942.17
Profitability
Net Income$-10,290,000.00N/A$-37,180,000.00$-106,370,000.00$-36,170,000.00
EPSN/AN/AN/A($2.49)($0.89)
Trailing P/E Ratio0.000.000.00N/AN/A
Forward P/E Ratio4.53N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-360.35%-29.53%
Return on Equity (ROE)-302.90%N/A-566.22%-64.36%-3.75%
Return on Assets (ROA)-174.74%N/A-32.99%-53.22%-3.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.03%N/AN/AN/A
Current Ratio6.19%81.20%41.56%8.00%18.08%
Quick Ratio6.19%81.20%41.56%8.00%18.08%
Ownership Information
Institutional Ownership Percentage30.18%59.43%91.20%67.01%90.78%
Insider Ownership Percentage37.50%1.80%N/A5.70%10.93%
Miscellaneous
Employees2363876141
Shares Outstanding51.62 million45.45 million38.16 million49.83 million20.17 million
Next Earnings Date3/3/2021 (Estimated)3/4/2021 (Estimated)3/1/2021 (Estimated)5/10/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.